+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Continuous Renal Replacement Therapy Devices Market 2018-2022 - Product Image

Global Continuous Renal Replacement Therapy Devices Market 2018-2022

  • ID: 4751621
  • Report
  • December 2018
  • Region: Global
  • 129 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic
  • MORE
The incidence of AKIs in ICU patients is increasing, and severe cases of AKI are mostly treated through renal replacement therapy (RRT). CRRT is the most preferred therapy in ICU patients suffering from AKI due to their hemodynamic instability. Acute renal failures are common and can lead to serious complications in severely ill patients. The use of renal replacement therapy has a major impact in terms of treating acute renal failure. The timing of the initiation of the renal replacement therapy, the selection of the specific modality of the therapy, and the intensity of the therapy are the most important factors in determining the effectiveness of renal replacement therapy in treating acute renal failure. The analysts have predicted that the continuous renal replacement therapy devices market will register a CAGR of over 7% by 2022.

Market Overview

Advantages of CRRT over IRRT

CRRT offers some key clinical advantages over intermittent blood purification techniques such as intermittent hemodialysis (IHD), sustained low-efficiency daily dialysis (SLEDD), and peritoneal dialysis (PD).

Limitations of and complications involved in CRRT

Technical limitations such as the interaction between the technician or medical staff and the machine inhibit the quality of real-time data analytics carried out. These limitations apply both to the way in which patients are clinically managed and how the technology is used.

For the detailed list of factors that will drive and challenge the growth of the continuous renal replacement therapy devices market during the 2018-2022, view this report.

Competitive Landscape

The continuous renal replacement therapy devices market is moderately concentrated with companies, the increasing competition in mature markets, will further trigger CRRT device manufacturers to focus on the emerging markets during the forecast period. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY MODALITY
  • Segmentation by modality
  • Comparison by modality
  • Global continuous venovenous hemofiltration (CVVH) market
  • Global continuous venovenous hemodiafiltration (CVVHDF) market
  • Global continuous venovenous hemodialysis (CVVHD) market
  • Global slow continuous ultrafiltration (SCUF) market
  • Market opportunity by modality
PART 08: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Global consumables market
  • Global systems market
  • Market opportunity by product
PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • CRRT devices market in EMEA
  • CRRT devices market in Americas
  • CRRT devices market in APAC
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Opportunities in emerging markets
  • Focus on miniaturization and wearable technology and that for infant and
  • pediatric applications
  • Technological advances in CRRT
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Asahi Kasei Medical (a subsidiary of Asahi Kasei Group)
  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Global urology devices market
Exhibit 02: Global urology devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Modality - Market share 2017-2022 (%)
Exhibit 19: Comparison by modality
Exhibit 20: Continuous venovenous hemofiltration (CVVH) - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Continuous venovenous hemofiltration (CVVH) - Year-over-year growth 2018-2022 (%)
Exhibit 22: Continuous venovenous hemodiafiltration (CVVHDF) - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Continuous venovenous hemodiafiltration (CVVHDF) - Year-over-year growth 2018-2022 (%)
Exhibit 24: Continuous venovenous hemodialysis (CVVHD) - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Continuous venovenous hemodialysis (CVVHD) - Year-over-year growth 2018-2022 (%)
Exhibit 26: Slow continuous ultrafiltration (SCUF) - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Slow continuous ultrafiltration (SCUF) - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by modality
Exhibit 29: Product - Market share 2017-2022 (%)
Exhibit 30: Comparison by product
Exhibit 31: Consumables - Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Consumables - Year-over-year growth 2018-2022 (%)
Exhibit 33: Systems - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Systems - Year-over-year growth 2018-2022 (%)
Exhibit 35: Market opportunity by product
Exhibit 36: Customer landscape
Exhibit 37: Global - Market share by geography 2017-2022 (%)
Exhibit 38: Regional comparison
Exhibit 39: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 40: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 41: Top three countries in EMEA
Exhibit 42: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 43: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 44: Top three countries in Americas
Exhibit 45: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 46: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 47: Top three countries in APAC
Exhibit 48: Market opportunity
Exhibit 49: Percentage of aging population 65 years and above (%)
Exhibit 50: Vendor landscape
Exhibit 51: Landscape disruption
Exhibit 52: Vendors covered
Exhibit 53: Vendor classification
Exhibit 54: Market positioning of vendors
Exhibit 55: Asahi Kasei Medical - Overview
Exhibit 56: Asahi Kasei Medical - Products category
Exhibit 57: Asahi Kasei Group - Geographic focus
Exhibit 58: Asahi Kasei Medical - Category focus
Exhibit 59: Asahi Kasei Medical - Key offerings
Exhibit 60: Asahi Kasei Medical - Key customers
Exhibit 61: B. Braun Melsungen - Overview
Exhibit 62: B. Braun Melsungen - Business segments
Exhibit 63: B. Braun Melsungen - Organizational developments
Exhibit 64: B. Braun Melsungen - Geographic focus
Exhibit 65: B. Braun Melsungen - Segment focus
Exhibit 66: B. Braun Melsungen - Key offerings
Exhibit 67: B. Braun Melsungen - Key customers
Exhibit 68: Baxter - Overview
Exhibit 69: Baxter - Business segments
Exhibit 70: Baxter - Organizational developments
Exhibit 71: Baxter - Geographic focus
Exhibit 72: Baxter - Segment focus
Exhibit 73: Baxter - Key offerings
Exhibit 74: Baxter - Key customers
Exhibit 75: Fresenius Medical Care - Overview
Exhibit 76: Fresenius Medical Care - Business segments
Exhibit 77: Fresenius Medical Care - Organizational developments
Exhibit 78: Fresenius Medical Care - Geographic focus
Exhibit 79: Fresenius Medical Care - Segment focus
Exhibit 80: Fresenius Medical Care - Key offerings
Exhibit 81: Fresenius Medical Care - Key customers
Exhibit 82: Medtronic - Overview
Exhibit 83: Medtronic - Business segments
Exhibit 84: Medtronic - Organizational developments
Exhibit 85: Medtronic - Geographic focus
Exhibit 86: Medtronic - Segment focus
Exhibit 87: Medtronic - Key offerings
Exhibit 88: Medtronic - Key customers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic
  • MORE
Global Continuous Renal Replacement Therapy Devices Market 2018-2022

The analyst recognizes the following companies as the key players in the global continuous renal replacement therapy devices market: Asahi Kasei Medical (a subsidiary of Asahi Kasei Group), B. Braun Melsungen, Baxter, Fresenius Medical Care, Medtronic.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing competition in mature markets, will further trigger CRRT device manufacturers to focus on the emerging markets during the forecast period.”

According to the report, one of the major drivers for this market is the increase in incidence of acute kidney injury (AKI) and associated risk factors.

Further, the report states that one of the major factors hindering the growth of this market is limitations of and complications involved in CRRT

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Asahi Kasei Medical (a subsidiary of Asahi Kasei Group)
  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic
Note: Product cover images may vary from those shown
Adroll
adroll